(19)
(11) EP 0 557 526 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.08.2003 Bulletin 2003/33

(45) Mention of the grant of the patent:
02.04.2003 Bulletin 2003/14

(21) Application number: 92916814.4

(22) Date of filing: 06.08.1992
(51) International Patent Classification (IPC)7: C07D 487/04, A61K 31/55
// (C07D487/04, 223:00, 209:00)
(86) International application number:
PCT/JP9201/009
(87) International publication number:
WO 9300/3032 (18.02.1993 Gazette 1993/05)

(54)

PYRROLOAZEPINE COMPOUND

PYRROLOAZEPINVERBINDUNGEN

COMPOSE DE PYRROLOAZEPINE

(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE

(30) Priority: 07.08.1991 JP 22119291

(43) Date of publication of application:
01.09.1993 Bulletin 1993/35

(73) Proprietor: Daiichi Suntory Pharma Co., Ltd.
Tokyo (JP)

(72) Inventors:
  • MIZUNO, Akira
    Nishigyoku Kyotoshi Kyoto 610-11 (JP)
  • MIYA, Mikiko
    Tsukuba-shi Ibaragi 305 (JP)
  • INOMATA, Norio
    Mino-shi Osaka 562 (JP)
  • TATSUOKA, Toshio
    Nishinomiya-shi Hyogo 662 (JP)
  • ISHIHARA, Takafumi
    Takatsuki-shi Osaka 569 (JP)

(74) Representative: Wächtershäuser, Günter, Prof. Dr. 
Patentanwalt, Tal 29
80331 München
80331 München (DE)


(56) References cited: : 
EP-A- 0 441 349
JP-T- 2 500 738
 JP-A- 62 161 786
   
  • Journal of Natural Products, Vol. 48, No. 1, p. 47-53 (1985).
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).